NVST
Envista Holdings Corp

399
Loading...
Loading...
News
all
press releases
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Zacks·1h ago
News Placeholder
More News
News Placeholder
Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up
ALC's UNITY VCS shows faster, more efficient cataract and vitreoretinal surgery results, lifting shares after study presentations.
Zacks·3h ago
News Placeholder
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay shares surge after the FDA cleared its accelerated Deep TMS protocol, offering faster depression treatment with strong clinical results.
Zacks·1d ago
News Placeholder
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Labcorp's $225M acquisition of BioReference Health select assets boosts its oncology diagnostics portfolio and expands patient access nationwide.
Zacks·1d ago
News Placeholder
ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5
Intuitive Surgical unveils real-time surgical insights on its da Vinci 5, enhancing precision, safety, and efficiency with advanced software features.
Zacks·2d ago
News Placeholder
GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.
Zacks·2d ago
News Placeholder
MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care
Merit Medical secures CE Mark for Embosphere, expanding its use in knee osteoarthritis treatment with a minimally invasive alternative.
Zacks·3d ago
News Placeholder
QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio
QIAGEN secures CE-IVDR certification for its full QIAstat-Dx portfolio, boosting its diagnostics arm and lifting shares.
Zacks·3d ago
News Placeholder
Why Envista (NVST) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·6d ago
News Placeholder
Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs
EXAS introduces Cancerguard, a blood test that detects more than 50 cancers, sending shares up after its U.S. debut.
Zacks·6d ago

Latest NVST News

View

Advertisement. Remove ads.

Advertisement. Remove ads.